Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Abdel-Rahman O (2018) Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease: an individual patient data analysis of three clinical trials. Strahlenther Onkol. https://doi.org/10.1007/s00066-018-1343-x

    Article  PubMed  Google Scholar 

  2. 2.

    Abdel-Rahman O, Cheung WY (2018) Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study. Med Oncol 35:68

    Article  PubMed  Google Scholar 

  3. 3.

    Budach W, Bolke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer—a meta-analysis of randomized trials- an update. Radiat Oncol 10:258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Early Breast Cancer Trialists’ Collaborative Group, Mcgale P, Taylor C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127–2135

    Article  Google Scholar 

  5. 5.

    Eiermann W, Pienkowski T, Crown J et al (2011) Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2‑normal, node-positive breast cancer: BCIRG-005 trial. J Clin Oncol 29:3877–3884

    Article  CAS  PubMed  Google Scholar 

  6. 6.

    Fernandez-Cuesta L, Oakman C, Falagan-Lotsch P et al (2012) Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial. Breast Cancer Res 14:R70

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Mackey JR, Martin M, Pienkowski T et al (2013) Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. Lancet Oncol 14:72–80

    Article  CAS  PubMed  Google Scholar 

  8. 8.

    Mcbride A, Allen P, Woodward W et al (2014) Locoregional recurrence risk for patients with T1,2 breast cancer with 1–3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys 89:392–398

    Article  PubMed  Google Scholar 

  9. 9.

    Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327

    Article  CAS  PubMed  Google Scholar 

  10. 10.

    Whelan TJ, Olivotto IA, Parulekar WR et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373:307–316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to PD Dr. med. Christiane Matuschek.

Ethics declarations

Conflict of interest

C. Matuschek, D. Krug, R.J. Klement and R. Baumann declare that they have no competing interests.

Additional information

This comment refers to the article available at https://doi.org/10.1007/s00066-018-1343-x.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Matuschek, C., Krug, D., Klement, R.J. et al. Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials. Strahlenther Onkol 195, 306–307 (2019). https://doi.org/10.1007/s00066-018-1411-2

Download citation